⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
accessnewswire.com
RARE
Pomerantz LLP Updates Shareholders on Legal Action Brought Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
RARE CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026 Ready to Announce with Confidence?
newsfilecorp.com
RARE
Levi & Korsinsky, LLP: Rare Stock Loss Quantifies Investor Damages Following Phase III Study Failure Disclosure
globenewswire.com
RARE
INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - RGRD Law
globenewswire.com
RARE
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
RARE
RARE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ultragenyx Pharmaceutical Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RARE
Pomerantz LLP Reminds Shareholders: Securities Lawsuit Has Been Filed Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Pomerantz LLP Updates Investors on Legal Action Brought Against Ultragenyx Pharmaceutical Inc. – RARE
accessnewswire.com
RARE
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
RARE